Oxford Nanopore Technologies PLC Capital Markets Day Transcript
(video playing)
Good afternoon, everybody in the room, and all of you online. Welcome to our first Capital Markets Day. So please be gentle with us. I'm going to talk and set the stage for today's Capital Markets Day about vision and growth. As I hope most of you know, the company's goal is to enable the analysis of any living thing by anyone, anywhere.
I want to talk about a brief overview of the company and our history, our journey, and our future, setting the stage for the presentations today. So we are a single-molecule sensing platform company. We're focused on DNA/RNA analysis, sequencing genomic analysis. At the heart of everything we do is innovation. And you'll hear from Rosemary later.
The life science research tools market, which I will abbreviate to research markets, is a $6.2 billion market, growing at 15% to 18% per annum. We're growing much faster than that. The potential for applied markets runs into in excess of $150 billion. And then the second part of today, we'll be talking about how we are uniquely
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |